Back to User profile » Dr Elias Jabbour

Papers published by Dr Elias Jabbour:


Clinical Value of Measurable Residual Disease in Acute Lymphoblastic Leukemia

Hein K, Short N, Jabbour E, Yilmaz M

Blood and Lymphatic Cancer: Targets and Therapy 2022, 12:7-16

Published Date: 19 March 2022

Nilotinib for the treatment of chronic myeloid leukemia: An evidence-based review

Elias Jabbour, Jorge Cortes, Hagop Kantarjian

Core Evidence 2009, 4:207-213

Published Date: 5 October 2009

Development and targeted use of nilotinib in chronic myeloid leukemia

Carmen Fava, Hagop Kantarjian, Jorge Cortes, Elias Jabbour

Drug Design, Development and Therapy 2008, 2:233-243

Published Date: 10 November 2008